title: [Corrigendum] MicroRNA-320a inhibits tumor invasion by targeting neuropilin 1 and is associated with liver metastasis in colorectal cancer.
abstract: After carefully checking the original data of migration and invasion experiment, we find we had selected the wrong picture to show the effect of microRNA320a on the migration of LoVo cells. The corrected version of Fig. 6A shown below contains appropriate representative images. We apologize for the error and appreciate the opportunity to correct the scientific record. All authors agree with this correction. [the original article was published in the Oncology Reports 27: 685-694, 2012 DOI: 10.3892/or.2011.1561]
authors: Institute of Clinical Molecular Biology, Peking University, People's Hospital, Beijing 100044, P.R. China.
authors: Yujun
authors: Y
authors: Zhang
authors: Institute of Clinical Molecular Biology, Peking University, People's Hospital, Beijing 100044, P.R. China.
authors: Xiangjun
authors: X
authors: He
authors: Institute of Clinical Molecular Biology, Peking University, People's Hospital, Beijing 100044, P.R. China.
authors: Yulan
authors: Y
authors: Liu
authors: Department of General Surgery, Peking University, People's Hospital, Beijing 100044, P.R. China.
authors: Yingjiang
authors: Y
authors: Ye
authors: Department of General Surgery, Peking University, People's Hospital, Beijing 100044, P.R. China.
authors: Hui
authors: H
authors: Zhang
authors: Institute of Clinical Molecular Biology, Peking University, People's Hospital, Beijing 100044, P.R. China.
authors: Peiying
authors: P
authors: He
authors: Institute of Clinical Molecular Biology, Peking University, People's Hospital, Beijing 100044, P.R. China.
authors: Qi
authors: Q
authors: Zhang
authors: Department of General Surgery, Peking University, People's Hospital, Beijing 100044, P.R. China.
authors: Lingyi
authors: L
authors: Dong
authors: Institute of Clinical Molecular Biology, Peking University, People's Hospital, Beijing 100044, P.R. China.
authors: Yujing
authors: Y
authors: Liu
authors: Institute of Clinical Molecular Biology, Peking University, People's Hospital, Beijing 100044, P.R. China.
authors: Jianqiang
authors: J
authors: Dong